The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications

A conference sponsored by the National Digestive Diseases Advisory Board

Mitchell L. Shiffman, Lennox J Jeffers, Jay H. Hoofnagle, Tommie Sue Tralka

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

TIPS is a new and exciting modality for treatment of portal hypertension and its complications. Indications for TIPS remain to be better defined in terms of efficacy and cost-benefit in relationship to other established modes of therapy of portal hypertension. Prospective, randomized controlled trials are needed for these comparisons. Until the role of TIPS in the routine management of the complications of portal hypertension is better defined, TIPS should be used only in situations in which conventional medical and endoscopic therapies have failed.

Original languageEnglish
Pages (from-to)1591-1597
Number of pages7
JournalHepatology
Volume22
Issue number5
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Portal Hypertension
Cost-Benefit Analysis
Randomized Controlled Trials
Therapeutics

ASJC Scopus subject areas

  • Hepatology

Cite this

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications : A conference sponsored by the National Digestive Diseases Advisory Board. / Shiffman, Mitchell L.; Jeffers, Lennox J; Hoofnagle, Jay H.; Sue Tralka, Tommie.

In: Hepatology, Vol. 22, No. 5, 01.01.1995, p. 1591-1597.

Research output: Contribution to journalArticle

@article{7b1b8d66c741463ea0a63ded0acfd955,
title = "The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board",
abstract = "TIPS is a new and exciting modality for treatment of portal hypertension and its complications. Indications for TIPS remain to be better defined in terms of efficacy and cost-benefit in relationship to other established modes of therapy of portal hypertension. Prospective, randomized controlled trials are needed for these comparisons. Until the role of TIPS in the routine management of the complications of portal hypertension is better defined, TIPS should be used only in situations in which conventional medical and endoscopic therapies have failed.",
author = "Shiffman, {Mitchell L.} and Jeffers, {Lennox J} and Hoofnagle, {Jay H.} and {Sue Tralka}, Tommie",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0270-9139(95)90169-8",
language = "English",
volume = "22",
pages = "1591--1597",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications

T2 - A conference sponsored by the National Digestive Diseases Advisory Board

AU - Shiffman, Mitchell L.

AU - Jeffers, Lennox J

AU - Hoofnagle, Jay H.

AU - Sue Tralka, Tommie

PY - 1995/1/1

Y1 - 1995/1/1

N2 - TIPS is a new and exciting modality for treatment of portal hypertension and its complications. Indications for TIPS remain to be better defined in terms of efficacy and cost-benefit in relationship to other established modes of therapy of portal hypertension. Prospective, randomized controlled trials are needed for these comparisons. Until the role of TIPS in the routine management of the complications of portal hypertension is better defined, TIPS should be used only in situations in which conventional medical and endoscopic therapies have failed.

AB - TIPS is a new and exciting modality for treatment of portal hypertension and its complications. Indications for TIPS remain to be better defined in terms of efficacy and cost-benefit in relationship to other established modes of therapy of portal hypertension. Prospective, randomized controlled trials are needed for these comparisons. Until the role of TIPS in the routine management of the complications of portal hypertension is better defined, TIPS should be used only in situations in which conventional medical and endoscopic therapies have failed.

UR - http://www.scopus.com/inward/record.url?scp=0028886215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028886215&partnerID=8YFLogxK

U2 - 10.1016/0270-9139(95)90169-8

DO - 10.1016/0270-9139(95)90169-8

M3 - Article

VL - 22

SP - 1591

EP - 1597

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -